Skip to main content

An Exploratory, Multicenter, Randomized, double-blind, placebo-controlled study evaluating the effect and safety of pitolisant in children and adolescents with Autism Spectrum Disorders.

Open
  • Protocol code: P21-01
  • EudraCT code: _
  • Research group: Psychiatry, Mental Health and Addictions
  • Service: Psychiatry
  • Principal investigator:  Gisbert Gustemps, Laura
  • Pathology: Trastorns mentals i del comportament
  • Phase: Fase II